The lithium transition‐metal phosphate LiFe0.6Mn0.4PO4 has two operating potentials, 3.5 V and 4.1 V, which is favorable for increasing the energy and power densities of lithium‐ion batteries (LIBs). To study the compatibility between LiFe0.6Mn0.4PO4 and electrolytes, lithium bis(oxalate)borate (LiBOB) is chosen as the lithium salt, based upon ethylene carbonate (EC), dimethyl carbonate (DMC), and dimethyl sulfite (DMS) as the supporting electrolyte solvents. The electrochemical performances of lithium hexafluorophosphate (LiPF6)‐based and LiBOB‐based electrolytes are compared. The combination of LiBOB and DMS can facilitate the formation of an effective passivation film. In addition, LiBOB‐EC/DMS electrolyte exhibits better cycle and rate performance. The results suggest that LiBOB‐EC/DMS electrolyte has good compatibility with LiFe0.6Mn0.4PO4, which makes it an attractive electrolyte for rechargeable LIBs based upon LiFe0.6Mn0.4PO4 cathodes.
Nanomicro spheres of LiNi0.5Mn1.5O4 materials are prepared by carbonate coprecipitation method. The effect of calcination temperatures on morphology and electrochemical property is explored. Results show that the structure of the material becomes more compact with the increase of the temperature, which is propitious to the improvement of electrical conductivity and activation level of the material. The charge–discharge tests show that the sample obtained at 850 °C (LNMO850) exhibits optimal rate capability and cyclic stability, due to the fact that LNMO850 has a high diffusion coefficient, which is propitious to the improvement of electrical conductivity and activation level of the material.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.